Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 11 to 14 of 14

Publication Record

Connections

Hepatitis A in day care centers.
Crawford F, Vermund SH
(1985) J Sch Health 55: 378-81
MeSH Terms: Adolescent, Adult, Child, Child Day Care Centers, Child, Preschool, Hepatitis A, Humans, Immunization, Passive, Risk, United States
Added March 5, 2014
0 Communities
1 Members
0 Resources
10 MeSH Terms
Soluble glucan and lymphokine-activated killer (LAK) cells in the therapy of experimental hepatic metastases.
Sherwood ER, Williams DL, McNamee RB, Jones EL, Browder IW, Di Luzio NR
(1988) J Biol Response Mod 7: 185-98
MeSH Terms: Animals, Bone Marrow, Glucans, Immunization, Passive, Interleukin-2, Killer Cells, Natural, Kupffer Cells, Liver Neoplasms, Experimental, Lymphoma, Large B-Cell, Diffuse, Male, Mice, Mice, Inbred C57BL, Spleen, Transplantation, Isogeneic
Added October 18, 2015
0 Communities
1 Members
0 Resources
14 MeSH Terms
"Lymphokine activated killing" as treatment for human cancer: clinical extrapolations from laboratory studies with interleukin-2 expanded leukocytes.
Sondel PM, Hank JA, Kohler PC, Chen BP, Sosman J
(1989) Prog Clin Biol Res 288: 151-60
MeSH Terms: Animals, Clinical Trials as Topic, Cytotoxicity, Immunologic, Humans, Immunization, Passive, Interleukin-2, Killer Cells, Natural, Lymphocyte Activation, Lymphocytosis, Mice, Neoplasms, Neoplasms, Experimental
Added March 5, 2014
0 Communities
1 Members
0 Resources
12 MeSH Terms
In vivo activation of lymphokine-activated killer activity with interleukin-2: prospects for combination therapies.
Sosman JA, Hank JA, Sondel PM
(1990) Semin Oncol 17: 22-30; discussion 38-41
MeSH Terms: Antibodies, Monoclonal, Blood Transfusion, Combined Modality Therapy, Humans, Immunization, Passive, Interferon Type I, Interleukin-2, Killer Cells, Lymphokine-Activated, Lymphocyte Activation, Neoplasms, Recombinant Proteins, Time Factors
Added March 5, 2014
0 Communities
1 Members
0 Resources
12 MeSH Terms